Complete cytoreduction for ovarian cancer: Is it enough for long‐term survival?
- 24 August 2018
- journal article
- letter
- Published by Wiley in Journal of Surgical Oncology
- Vol. 118 (3) , 593-594
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerNew England Journal of Medicine, 2018
- The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity scoreJournal of Surgical Oncology, 2016
- Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III StudyAnnals of Surgical Oncology, 2014
- Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi‐institutional studyBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosisJournal of Surgical Oncology, 2008